Niagen Bioscience (NAGE) Change in Receivables (2011 - 2020)

Niagen Bioscience (NAGE) has 8 years of Change in Receivables data on file, last reported at -$1.3 million in Q1 2020.

• On a quarterly basis, Change in Receivables fell 238.7% year-over-year to -$1.3 million in Q1 2020; TTM through Mar 2020 was -$2.3 million, a 267.58% decrease from a year earlier, with the FY2019 full-year figure at -$44000.0, down 103.96% from the prior year.
• Change in Receivables for Q1 2020 stood at -$1.3 million, down from $1.5 million in the prior quarter.
• Over the last five years, Change in Receivables for NAGE reached as high as $1.5 million in Q4 2019 and fell as low as -$2.5 million in Q3 2016.
• Historically, Change in Receivables has averaged -$144236.2 across 5 years, with a median of $129138.0 in 2016.
• Across the five-year window, Change in Receivables jumped 366.18% in 2018 and sank 577.03% in 2019, its largest moves.
• Year by year, Change in Receivables stood at $181878.0 in 2016, then plunged by 405.15% to -$555000.0 in 2017, then soared by 174.59% to $414000.0 in 2018, then surged by 273.43% to $1.5 million in 2019, then plunged by 185.77% to -$1.3 million in 2020.
• Per Business Quant data, the three most recent Change in Receivables figures were -$1.3 million in Q1 2020, $1.5 million in Q4 2019, and -$217000.0 in Q3 2019.